Treatment of juvenile xanthogranuloma

Pediatric Blood and Cancer

Volumn 51, Issue 1, 2008, Pages 130-133

  Stover, Daniel G ^a   Alapati, Srilatha ^b   Regueira, Osvaldo ^b   Turner, Curtis ^b   Whitlock, James A ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Juvenile xanthogranuloma; Langerhans cell histiocytosis

Indexed keywords

ANTINEOPLASTIC AGENT; CD68 ANTIGEN; CLADRIBINE; CLOFIBRATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; IMMUNOGLOBULIN; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; PROTEIN S 100; STEROID; T6 ANTIGEN; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES INSIPIDUS; FEMALE; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; JUVENILE XANTHOGRANULOMA; MALE; PRIORITY JOURNAL; SKIN INFILTRATE; SYMPTOMATOLOGY; SYSTEMIC DISEASE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; MALE; TREATMENT OUTCOME; XANTHOGRANULOMA, JUVENILE;

EID: 44149128002     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21523     Document Type: Article

References (14)

1. Janssen D, Harms D. Juvenile xanthogranuloma in childhood and adolescence: A clinicopathologic study of 129 patients from the Kiel pediatric tumor registry. Am J Surg Pathol 2005; 29:21-28.
2. Dehner LP. Juvenile xanthogranulomas in the first two decades of life: A clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 2003;27:579-593.
3. Weitzman S, Jaffe R. Uncommon histiocytic disorders: The non-Langerhans cell histiocytoses. Pediatr Blood Cancer 2005;45:256-264.
4. Freyer DR, Kennedy R, Bostrom BC, et al. Juvenile xanthogranuloma: Forms of systemic disease and their clinical implications. J Pediatr 1996;129:227-237.
5. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995;127:1-11.
6. Patrizi A, Neri I, Bianchi F, et al. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports. Dermatology 2004;209:57-61.
7. Gadner H, Heitger A, Grois N, et al. Treatment strategy for disseminated Langerhans cell histiocytosis. Dal HX-83 Study Group. Med Pediatr Oncol 1994;23:72-80.
8. Dolken R, Weigel S, Schroder H, et al. Treatment of severe disseminated juvenile systemic xanthogranuloma with multiple lesions in the central nervous system. J Pediatr Hematol Oncol 2006;28:95-97.
9. Chantranuwat C. Systemic form of juvenile xanthogranuloma: Report of a case with liver and bone marrow involvement. Pediatr Dev Pathol 2004;7:646-648.
10. Nakatani T, Morimoto A, Kato R, et al. Successful treatment of congenital systemic juvenile xanthogranuloma with langerhans cell histiocytosis-based chemotherapy. J Pediatr Hematol Oncol 2004;26:371-374.
11. Labalette P, Guilbert F, Jourdel D, et al. Bilateral multifocal uveal juvenile xanthogranuloma in a young boy with systemic disease. Graefes Arch Clin Exp Ophthalmol 2002;240:506-509.
12. Eggli KD, Caro P, Quiogue T, et al. Juvenile xanthogranuloma: Non-x histiocytosis with systemic involvement. Pediatr Radiol 1992;22:374-376.
13. Flach DB, Winkelmann RK. Juvenile xanthogranuloma with central nervous system lesions. J Am Acad Dermatol 1986;14:405-411.
14. Unuvar E, Devecioglu O, Akcay A, et al. Successful therapy of systemic xanthogranuloma in a child. J Pediatr Hematol Oncol 2007;29:425-427.